Evidence map›Paper›PMID 41714629›Full record

ArticleNature communications2026

Enhancing microbial metabolic capacity through high-energy electron beam-induced intense structural variations.

Xinyuan Feng, Zilong Li, Yifei Zhang, Jingping Xu, Zhenguo Xin, Jinling Yang, Mengjun Wu, Sufen Zhang, Zhiyang Yu, Dongjing Qu and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xinyuan FengDepartment of Gastroenterology of the Second Affiliated Hospital and Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, China.
Zilong LiState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yifei ZhangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Jingping XuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Zhenguo XinState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Jinling YangDepartment of Gastroenterology of the Second Affiliated Hospital and Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, China.
Mengjun WuDepartment of Gastroenterology of the Second Affiliated Hospital and Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, China.
Sufen ZhangInstitute of Nuclear-Agricultural Science, Accelerator Center of Zhejiang University, College of Agriculture and Biotechnology, Zhejiang University, Hangzhou, China.
Zhiyang YuInstitute of Nuclear-Agricultural Science, Accelerator Center of Zhejiang University, College of Agriculture and Biotechnology, Zhejiang University, Hangzhou, China.
Dongjing QuKey Laboratory of Feed Antibiotics Replacement Technology, Ministry of Agriculture and Rural Affairs, Sinagri Yingtai Bio-peptide Co., Ltd, Linzhou, China.
Tao HeKey Laboratory of Feed Antibiotics Replacement Technology, Ministry of Agriculture and Rural Affairs, Sinagri Yingtai Bio-peptide Co., Ltd, Linzhou, China.
Jinmei WuKey Laboratory of Feed Antibiotics Replacement Technology, Ministry of Agriculture and Rural Affairs, Sinagri Yingtai Bio-peptide Co., Ltd, Linzhou, China.
Juping YuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Wei LiuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Mohammad R SeyedsayamdostDepartment of Chemistry, Princeton University, Princeton, NJ, USA. mrseyed@princeton.edu.ORCID http://orcid.org/0000-0003-2707-4854
Weishan WangState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. wangws@im.ac.cn.ORCID http://orcid.org/0000-0001-7827-2696
Fei XuDepartment of Gastroenterology of the Second Affiliated Hospital and Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, China. fxu23@zju.edu.cn.ORCID http://orcid.org/0000-0002-0372-5643

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-molecule metabolites are key pharmaceutical resources embedded in complex organismal metabolomes. Scalable microbial production depends on metabolic activation capacity, which in turn requires efficient genetic variation. Structural variants (SVs), key drivers of phenotypic diversity, are pivotal for organism evolution, yet their highly efficient induction remains challenging. While DNA double-strand breaks (DSBs) facilitate SVs formation, existing mutagenesis technologies struggle to balance high DSB efficiency with cellular preservation, particularly in microbial strain improvement for metabolite production. Conventional irradiation methods suffer from low SVs induction rates, making strain enhancement a lengthy and labor-intensive process. Here, we systematically compare six irradiation technologies in Streptomyces lividans 1326 and identify high-energy pulsed electron beams (HEPE) as an approach which effectively induces strong DSBs while preserving cellular integrity. This results in extensive SVs that reshape genome sequences and 3D chromatin structure, leading to activation of secondary metabolite production. By integrating HEPE with high-throughput metabolomics (HEPE-HiTMS), we discover two secondary metabolites with unusual C-N linkage, respectively. Applied across various microorganisms, HEPE enables record-high clavulanic acid and microcin J25 production, and markedly increases lovastatin yields. With its ability to induce SVs with minimal cytotoxicity, HEPE represents a powerful tool for cryptic metabolite discovery and industrial strain development.

Indexed as

ElectronsMetabolic EngineeringStreptomyces lividansDNA Breaks, Double-StrandedGenome, BacterialMetabolomeMetabolomicsMutagenesis

Identifiers

PMID41714629
PMCPMC13031421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.